Dear Makkatack,
Yes and further to your comments the paper that is referred to here was SPECIFIC to Oncology. And published in the ONCOLOGY BUSINESS REVIEW in 2010.
As Phosphagenics does not manufacture Oncology products nor Pharmaceuticals I cant see how this has any bearing on what they have Published or have not published. The author was referring to the route to market for cancer treatments and is quite clear about his comments.
The paper being used for this premise "appears inconsistent" with what this company actually does, which is manufactures an excipient.
It has no relevance to this company or its prospects at all. There are other companies on HC that it would be relevant to though.
BSW
partnering for success, page-22
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 29193465 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 52745197 | 27 |
View Market Depth
| Last trade - 16.23pm 17/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable